With increasing competition in the emerging world, healthcare reforms, rising customer expectations, cost constraints and the on-going challenge of successfully bringing new drugs to market, it’s perhaps fair to say that the life sciences sector is under pressure.
Is an employee, who is excluded from a voluntary severance scheme on discriminatory grounds, entitled to receive the full amount of severance despite the fact she kept working for her employer? We report on the case of HM Land Registry v McGlue.
Find out how global expansion, mergers & acquisitions, and outsourcing are impacting employees' perceptions of the pharma, biotech and medical devices sectors. From market confidence to how likely professionals are to move role and what's driving these moves - take a look at our infographic for the latest insight from our US market trends report.
Employee confidence within the pharma, biotech and medical devices sectors is growing with 4 out of 5 professionals in the US citing they have no real concerns over their future job security, according to a new report published by Real.
It was been a busy time for Parliament this spring! The Enterprise and Regulatory Reform Bill received Royal Assent on 25th April 2013, there have been more developments in the saga of Employee Shareholders and BIS has published various implementation dates for forthcoming employment legislation. We report on these parliamentary developments.
As part of their “growth by acquisition” strategy, the pharmaceutical recruitment company; Pharma Consulting Group (PCG) has recently acquired Surrey based CSL Recruitment and Consulting Ltd.
As defined by Motley Fool, bioequivalence “uses a brand-name drug’s efficacy and safety data to show that any differences between it and a generic rival are statistically insignificant.”
Find out how global expansion, mergers & acquisitions, and outsourcing are impacting employees' perceptions of the pharma, biotech and medical devices sectors. From market confidence to how likely professionals are to move role and what's driving these moves - take a look at our infographic for the latest insight from our European salary and market trends report
Leading business intelligence provider GBI Research has released its latest research report, entitled “Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency”.
A half year review already? Yes! We have been recently inundated with Government proposals, action plans and legislative reform for the year ahead. Before January draws to a close, let us pause and consider what’s in store for the first half of this year.
Five years ago, recruiters faced an enormous challenge when trying to attract candidates for senior level positions within generics pharmaceutical companies – nobody wanted to work for a generics business.
Mike Ellingham, PR & Marketing Consultant
The year 2012 will soon pass into history, and what a year it was for biopharmaceuticals. In the United States, the Supreme Court affirmed the new healthcare reform law and exempted pharma companies from sales force overtime rules, the Food & Drug Administration (FDA) approved the first obesity drug in 13 years with Belviq, and billions of dollars changed hands as a result of government settlements.
As more and more sponsors engage contract research organizations (CROs) at the discovery phase and the complexity of outsourced studies rises, the ability to manage the relationships between site, CRO and sponsor becomes more and more vital.
Scott Vogelsberg of Datatrial
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her